Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
214.88
+3.65 (1.73%)
At close: Jan 30, 2026, 4:00 PM EST
215.00
+0.12 (0.06%)
After-hours: Jan 30, 2026, 7:58 PM EST
Cardinal Health Stock Forecast
Stock Price Forecast
The 12 analysts that cover Cardinal Health stock have a consensus rating of "Strong Buy" and an average price target of $210.67, which forecasts a -1.96% decrease in the stock price over the next year. The lowest target is $145 and the highest is $245.
Price Target: $210.67 (-1.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 4 |
| Buy | 7 | 7 | 7 | 6 | 7 | 7 |
| Hold | 4 | 4 | 4 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 14 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $224 → $245 | Buy | Maintains | $224 → $245 | +14.02% | Jan 29, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $221 → $237 | Buy | Maintains | $221 → $237 | +10.29% | Jan 15, 2026 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $190 → $244 | Hold → Strong Buy | Upgrades | $190 → $244 | +13.55% | Jan 9, 2026 |
| Barclays | Barclays | Buy Initiates $243 | Buy | Initiates | $243 | +13.09% | Dec 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $185 → $221 | Buy | Maintains | $185 → $221 | +2.85% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
259.95B
from 222.58B
Increased by 16.79%
Revenue Next Year
281.75B
from 259.95B
Increased by 8.38%
EPS This Year
10.00
from 6.45
Increased by 54.99%
EPS Next Year
11.19
from 10.00
Increased by 11.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 275.1B | 306.6B | |||
| Avg | 260.0B | 281.7B | |||
| Low | 239.1B | 252.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.6% | 17.9% | |||
| Avg | 16.8% | 8.4% | |||
| Low | 7.4% | -3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.69 | 12.04 | |||
| Avg | 10.00 | 11.19 | |||
| Low | 9.55 | 9.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 65.7% | 20.5% | |||
| Avg | 55.0% | 11.9% | |||
| Low | 48.0% | -4.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.